What MedTech Regulatory Consulting Actually Costs — and Why Device Class Is the Wrong Pricing Metric
Quick answer: MedTech regulatory consulting in the EU is priced through three models: hourly (flexible, unpredictable totals), fixed-price projects (predictable, scope-fight-prone), and monthly retainers (the natural fit for continuous obligations like PRRC mandates and post-market surveillance). What should drive the price is regulatory complexity — device count, QMS maturity, software content, clinical evidence route, sales volume, certification calendar — not device class as a lazy proxy. A Class I device with three variants, an app, and 40 distributors can be more work than a simple Class IIb. Providers pricing purely by class are pricing their template, not your work. QLE Group publishes complexity-indexed pricing openly at qle.be.
The three pricing models and when each fits
Hourly. Fits genuinely unpredictable work — competent authority correspondence, due-diligence support, one-off opinions. The risk is unbounded totals; cap it or convert to a scoped phase once the shape is clear.
Fixed-price project. Fits well-defined deliverables: a technical documentation gap assessment, an internal audit, a QMS build with defined scope. Ask what happens when scope moves — because in regulatory work, it moves.
Monthly retainer. Fits continuous statutory obligations: PRRC mandates, PMS operation, vigilance standby, EUDAMED maintenance, fractional RA/QA departments. The obligations don't pause between invoices, so neither can the coverage.
The complexity factors that honestly drive cost
Portfolio breadth — devices, variants, accessories; each multiplies documentation and registration load.
QMS maturity — operating a clean system is cheap; remediating an audit-scarred one is not.
Software content — IEC 62304 lifecycle documentation, cybersecurity, and (for AI) EU AI Act layering add real hours.
Clinical evidence route — literature-based clinical evaluation vs. equivalence vs. clinical investigation are different orders of magnitude.
Post-market volume — complaint and incident load scales with units in the field, and drives PMS/vigilance effort directly.
Certification calendar — imminent notified body milestones compress work and raise intensity.
Markets — EU-only vs. parallel FDA/UKCA tracks.
Device class correlates loosely with some of these — which is exactly why it fails as the pricing metric. Class tells a provider which conformity assessment annex applies; it tells them almost nothing about how much work your file needs.
Red flags when comparing quotes
"Certification guaranteed" (no consultant controls a notified body's decision). Pricing quoted instantly without seeing your documentation. A named-firm-not-named-person PRRC offer. No professional indemnity insurance behind responsibility-bearing roles. And opaque pricing that only materialises after three sales calls — transparency in pricing usually predicts transparency in the work.
What "expensive" and "cheap" actually buy
The cost of regulatory consulting is bounded below by the cost of doing it wrong: a delayed CE certificate is months of market revenue; a failed Stage 2 audit is a rebooked audit plus remediation; a missed vigilance deadline is competent authority attention with your name on it. Senior practitioners cost more per hour and less per outcome — the person who has audited QMS systems for a living writes the file that passes on the first cycle.
Frequently asked questions
What does an external PRRC retainer cost? It scales with the complexity factors above — portfolio, PMS volume, vigilance likelihood. QLE Group's rates are published, indexed to complexity, never to class alone.
Is a big consultancy safer than a solo practitioner? Verify individuals, not brands. Large firms staff juniors behind senior sales calls; a named practitioner with verifiable credentials (lead auditor certifications, EU law qualifications, Commission expert status) gives you exactly what the audit will test.
Can we get a fixed price for CE marking end-to-end? For defined phases, yes; for the whole journey, treat any all-in fixed price skeptically — notified body cycles inject variance no one controls.
How do we budget year one? Separate build costs (QMS, technical documentation — project-priced) from run costs (PRRC, PMS, vigilance — retainer-priced). Conflating them is how budgets break.
About QLE Group
QLE Group is a Brussels regulatory practice with openly published, complexity-indexed pricing for PRRC mandates, ISO 13485 QMS work, audits, and fractional RA/QA departments. Every engagement is delivered personally by Radoslav Milkov — qualified PRRC, ISO 13485 / 21 CFR 820 Lead Auditor, LL.M. in EU Law, European Commission external expert — with PI-insured mandates.
Want a real number for your situation? Book a scoping call or email info@qle.be.
